Butensky & Cohen Financial Security’s iShares Biotechnology ETF IBB Stock Holding History

Butensky & Cohen Financial Security’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-1,050	Closed	-$109K	–	91
2017 Q2	$109K	Sell	1,050 -30	-3%	-$2.96K	0.1%	78
2017 Q1	$106K	Sell	1,080 -141	-12%	-$13.5K	0.1%	76
2016 Q4	$108K	Hold	1,221	–	–	0.1%	75
2016 Q3	$118K	Hold	1,221	–	–	0.11%	75
2016 Q2	$105K	Hold	1,221	–	–	0.1%	74
2016 Q1	$106K	Sell	1,221 -15	-1%	-$1.34K	0.1%	74
2015 Q4	$139K	Sell	1,236 -6	-0.5%	-$651	0.14%	75
2015 Q3	$126K	Buy	1,242 +45	+4%	+$5.4K	0.13%	74
2015 Q2	$147K	Sell	1,197 -141	-11%	-$16.9K	0.15%	76
2015 Q1	$153K	Sell	1,338 -168	-11%	-$18.5K	0.15%	77
2014 Q4	$152K	Buy	+1,506	New	+$146K	0.15%	77

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Butensky & Cohen Financial Security's IBB Position: Q3 2017 in Review

Butensky & Cohen Financial Security sold out of iShares Biotechnology ETF (IBB) in Q3 2017, closing a stake of 1,050 shares — an estimated $109K sold.

Butensky & Cohen Financial Security first reported a position in IBB in Q4 2014 and held it in 11 quarters. The position peaked at $153K in Q1 2015. 584 funds tracked by Wall St. Rank hold IBB as of Q3 2017.

Butensky & Cohen Financial Security reported no remaining iShares Biotechnology ETF position as of Q3 2017 after selling out during the quarter.
Butensky & Cohen Financial Security sold 1,050 iShares Biotechnology ETF shares in Q3 2017, an estimated $109K.
Butensky & Cohen Financial Security first reported a position in iShares Biotechnology ETF in Q4 2014 and held it in 11 quarters.
Butensky & Cohen Financial Security's iShares Biotechnology ETF position peaked at $153K in Q1 2015.
584 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2017.

Based on Butensky & Cohen Financial Security's 13F filing for Q3 2017, filed 20 Oct 2017.